Puma Biotechnology Inc (NASDAQ:PBYI)
| 11.13 Delayed Data As of Jan 22 |  +0.54 / +5.09%Today’s Change | 5.50 Today|||52-Week Range 15.00 | +8.48% Year-to-Date |
Latest PBYI News | Press Releases
No recent news for Puma Biotechnology Inc.
Today’s Trading
| Previous close | 10.60 |
| Today’s open | 10.56 |
| Day’s range | 10.43 - 11.27 |
| Volume | 448,567 |
| Average volume (3 months) | 561,337 |
| Market cap | $441.4M |
Data as of 3:59pm ET, 01/22/2021
Growth & Valuation
| Earnings growth (last year) | +34.86% |
| Earnings growth (this year) | +27.18% |
| Earnings growth (next 5 years) | +95.60% |
| Revenue growth (last year) | +8.47% |
| P/E ratio | NM |
| Price/Sales | 1.25 |
| Price/Book | 24.92 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FULCFulcrum Therapeutics... | +0.01 | +0.07% |
| KLDOKaleido Biosciences ... | +0.40 | +3.32% |
| ---- | ||
| TXMDTherapeuticsMD Inc | +0.06 | +4.17% |
Data as of 4:54pm ET, 01/22/2021
Financials
| Next reporting date | March 4, 2021 |
| EPS forecast (this quarter) | -$0.29 |
| Annual revenue (last year) | $272.3M |
| Annual profit (last year) | -$75.6M |
| Net profit margin | -27.77% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Los Angeles, California |
Forecasts
